Results 151 to 160 of about 38,934 (294)

Islet Autoantibodies in Adult With Pituitary and Ovarian Autoimmunity: Implications for Type 1 Diabetes Screening

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5827-5833, July 2026.
ABSTRACT Purpose Type 1 diabetes is a chronic autoimmune disease characterised by progressive pancreatic β‐cell destruction and the early appearance of islet autoantibodies (islet‐AAb) during the pre‐symptomatic phases. Given the growing interest in screening and prevention of type 1 diabetes, this study aimed to assess the prevalence of pancreatic ...
Giuseppe Bellastella, Michela di Nuzzo, Miriam Longo, Paolo Cirillo, Antonietta Maio, Nicole Di Martino, Silvia Angelino, Paola Caruso, Lorenzo Scappaticcio, Maria Teresa Vietri, Maria Ida Maiorino, Katherine Esposito   +11 more
wiley   +1 more source

Diabetic Ketoacidosis Associated With the Menstrual Cycle: A Case of Catamenial Diabetic Ketoacidosis. [PDF]

Cureus
Alavi R, Chen C, Armando Sanchez Garcia H, Udeozo O.   +3 more
europepmc   +1 more source

Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR‐Based β‐Cell Replacement and Treg Immune Modulation Approaches

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5476-5491, July 2026.
ABSTRACT Background Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by the destruction of pancreatic β‐cells, resulting in lifelong dependence on exogenous insulin. Despite advances in insulin delivery and glucose monitoring technologies, patients remain at risk for acute and long‐term complications, underscoring the need for ...
Tzu‐Min Lin, Hui‐Fang Chang, Tzu‐Ching Lin, Cheng‐Han Lin, Yu‐Ling Sun, Chih‐Sheng Lin   +5 more
wiley   +1 more source

Euglycemic Diabetic Ketoacidosis: Clinical Suspicion and Diagnosis. [PDF]

Clin Med Insights Endocrinol Diabetes
Shukla R, Shrestha P, Khanal B, Regmi B.
europepmc   +1 more source

Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6301-6311, July 2026.
ABSTRACT Background Advanced diabetes technologies are standard of care for people with Type 1 diabetes (T1D). However, inequitable access contributes to disparities in outcomes. Purpose To characterise barriers and enablers to the use of advanced diabetes technologies among individuals with T1D and to synthesise these determinants using the ...
Laura Palermo, Joyeuse Senga, Patience Fakembe, Xi Zhu, Chris Walsh, Brenna Leslie, Rayzel Shulman, Justin Presseau, Maman Joyce Dogba, Ananya Banerjee, Rémi Rabasa‐Lhoret, Meranda Nakhla, Anne‐Sophie Brazeau, Leif Erik Lovblom, Holly O. Witteman, Lorraine L. Lipscombe, Alanna Weisman   +16 more
wiley   +1 more source

Leukocytosis in Diabetic Ketoacidosis Without Infection: A Diagnostic Challenge. [PDF]

Cureus
Ali K, Chandrasekara N, Cheng MW, Chandrasekara H.   +3 more
europepmc   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6347-6357, July 2026.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris, Charalampos Filippatos, Nikolaos‐Iason Tepetes, Maria Gavriatopoulou, Evangelos Terpos, Alexandros Briasoulis, Kimon Stamatelopoulos, Theodosios Filippatos   +7 more
wiley   +1 more source

Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. [PDF]

Med Sci (Basel)
Sieben NA, Blank S, Tabah A, White KC, Laupland KB, Edwards F, Attokaran A, Luke S, Kumar A, Whebell S, Parmar D, McCullough J, Garrett P, Ramanan M.   +13 more
europepmc   +1 more source

Severe Diabetic Ketoacidosis With Fatal Cerebral Edema in an Adult. [PDF]

Cureus
Rosa-Santiago SM, Font-Rivera DE, Fernandez-Gonzalez R, Olivera-Latorre S, Torres-Santiago N.   +4 more
europepmc   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source